Clinical Trials Browser

OTHER × Leukemia, Myeloid × daratumumab × Clear all

NCT04714372 2024-10-24

FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia

Phase 1 Completed

9 enrolled 16 charts

Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Leukemia, Myeloid, Acute